Recovery and purification process development for monoclonal antibody production.

MAbs
Hui F LiuRobert Bayer

Abstract

Hundreds of therapeutic monoclonal antibodies (mAbs) are currently in development, and many companies have multiple antibodies in their pipelines. Current methodology used in recovery processes for these molecules are reviewed here. Basic unit operations such as harvest, Protein A affinity chromatography, and additional polishing steps are surveyed. Alternative processes such as flocculation, precipitation, and membrane chromatography are discussed. We also cover platform approaches to purification methods development, use of high throughput screening methods, and offer a view on future developments in purification methodology as applied to mAbs.

References

Jan 1, 1987·Annals of Biomedical Engineering·I I Chen, S Saha
Apr 11, 1986·Journal of Chromatography·J Porath
Dec 1, 1985·Applied and Environmental Microbiology·C P Gerba, K Hou
Nov 1, 1980·Applied and Environmental Microbiology·K HouK S Zerda
Jul 9, 1999·Biotechnology and Bioengineering·D B Burns, A L Zydney
Feb 24, 2001·Journal of Chromatography. a·H L KnudsenG S Blank
Apr 5, 2001·Current Opinion in Biotechnology·R van Reis, A Zydney
Feb 8, 2002·Trends in Plant Science·Jürgen M Steiner, Wolfgang Löffelhardt
Jun 18, 2002·Journal of Chromatography. a·Raja Ghosh
Jul 20, 2002·Biologicals : Journal of the International Association of Biological Standardization·M KorneyevaS R Petteway
May 22, 2003·Journal of Virological Methods·Peter Roberts, Andrew Hope
Sep 11, 2003·Biotechnology and Bioengineering·Sherrie CurtisYuan Xu
Feb 3, 2004·Journal of Chromatography. a·Deborah K Follman, Robert L Fahrner
Apr 3, 2004·Biotechnology Progress·Mareia Frost Ebersold, Andrew L Zydney
Jul 14, 2004·Protein Expression and Purification·Tsutomu ArakawaDaisuke Ejima
Sep 30, 2004·Biologicals : Journal of the International Association of Biological Standardization·Huan TranDavid M Mann
Oct 7, 2004·Current Opinion in Biotechnology·Todd M PrzybycienLandon M Steele
Oct 7, 2004·Current Opinion in Biotechnology·Zivko L Nikolov, Susan L Woodard
Nov 6, 2004·Nature Biotechnology·Stephan HellwigRainer Fischer
Dec 15, 2004·Protein Expression and Purification·Jörg PetersWerner Schröder
Apr 7, 2005·Biotechnology and Bioengineering·Yinhua WanZhanfeng Cui
Apr 23, 2005·Journal of Chromatography. a·Lenore NorlingKurt Brorson
Jun 9, 2005·Biologicals : Journal of the International Association of Biological Standardization·Qiangyi LiAlex J Macleod
Jul 13, 2005·Journal of Chromatography. a·Michael PhillipsJeffrey Carter
Oct 7, 2005·Biotechnology and Applied Biochemistry·Glen R BoltonDan Lacasse
Apr 8, 2006·Biotechnology Progress·Joe X Zhou, Tim Tressel
Jul 4, 2006·Biotechnology and Bioengineering·Sanchayita GhoseSteven M Cramer
Jul 11, 2006·Advanced Drug Delivery Reviews·John R Birch, Andrew J Racher
Aug 10, 2006·Biotechnology and Bioengineering·C HarinarayanR van Reis
Sep 13, 2006·Journal of Chromatography. a·Joe X ZhouMichael Murphy
Oct 19, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Abhinav A ShuklaDuncan Low

❮ Previous
Next ❯

Citations

Oct 12, 2012·Applied Microbiology and Biotechnology·M Butler, A Meneses-Acosta
Aug 24, 2012·Protein Engineering, Design & Selection : PEDS·Deidra BetheaYiqing Feng
Jan 24, 2014·BioMed Research International·Mayank SaraswatHarry Holthofer
Mar 4, 2014·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Huihua QuQingguo Wang
May 16, 2014·Nanomedicine·Joana A LoureiroSandra Rocha
Feb 18, 2014·FEBS Letters·Haixia WuChristopher J Roberts
Jul 19, 2013·Biotechnology and Bioengineering·Min ZhangQi Chen
Mar 31, 2015·Journal of Pharmaceutical Sciences·Alexander JaraschHubert Kettenberger
Mar 31, 2015·Journal of Pharmaceutical Sciences·Yuemei YangBoyan Zhang
Feb 10, 2016·Molecular Therapy. Methods & Clinical Development·Timothy Weixin KwangShu Wang
Jan 16, 2016·ACS Infectious Diseases·Timothy WesslerSamuel K Lai
Feb 22, 2016·Journal of Chromatography. a·Benjamin TranPaul McDonald
May 12, 2012·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Jianing QianChristopher R Lowe
Jul 15, 2011·Journal of Chromatography. a·Abraham M Lenhoff
Aug 21, 2014·Biotechnology Progress·Sanchayita GhoseDouglas Cecchini
Nov 26, 2015·Journal of Chromatography. a·Dwight WintersKenneth Walker
Jul 19, 2012·Biotechnology and Bioengineering·James PollockSuzanne S Farid
May 30, 2012·Biotechnology Progress·P A Marichal-Gallardo, M M Alvarez
Mar 28, 2013·Biotechnology and Bioengineering·Benjamin SmejkalDariusch Hekmat
May 9, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·J McCueD Euwart
Apr 23, 2014·Biotechnology Journal·Varsha JoshiAnurag Rathore
Mar 3, 2015·Biotechnology and Bioengineering·Aaron NoyesTarit Mukhopadhyay
Oct 23, 2014·Biotechnology and Bioengineering·Julia Bach, Lisa Connell-Crowley
Nov 12, 2014·Biotechnology and Bioengineering·Melissa MunMichael W Laird
Feb 14, 2015·Biotechnology and Bioengineering·Piergiuseppe NestolaManuel J T Carrondo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.